DrugsControl Media Services
DrugsControl.org

News Detail

Zydus Lifesciences launches Rexigo in India (31-01-2024)

Ahmedabad, 31 Jan 2024: Zydus Lifesciences Ltd’s shares were up by 1.19 per cent after it launched the advanced prostate cancer drug Rexigo in India. This drug works by suppressing testosterone to manage prostate cancer. 

 

Rexigo is priced ₹......
View Details

Source : The Hindu BusinessLine
rexigo relugolix adt india ahmedabad zydus lifesciences ltd Health news

Related News